Abstract:Background Phosphoglycerate kinase 1 (PGK1) plays a crucial role in the glycolytic pathway and its overexpression has a negative impact on tumor development and prognosis. Resveratrol, a natural polyphenolic compound, has gained significant attention in recent years due to its anti-inflammatory, antioxidant, and anti-tumor properties. However, the mechanism by which resveratrol inhibits breast cancer growth, invasion, and metastasis through the PGK1 glycolytic pathway is still not fully understood. Therefore, this study aimed to investigate the inhibitory effects of resveratrol on breast cancer cell proliferation and invasive migration, as well as its ability to promote apoptosis in vitro. Additionally, the study examined the inhibitory effects of resveratrol on the growth of mouse breast cancer graft tumors in vivo. Methods We analyzed the expression levels of glycolytic enzymes in different breast tissues and their correlation with the prognosis of breast cancer patients through GEPIA and The Human Protein Atlas database. Wound healing assay, Transwell migration and invasion assay were used to study the effect of resveratrol on the biological functions of breast cancer. RT-qPCR and Western blot methods were used to explore the potential molecular mechanism of resveratrol inhibiting the development of breast cancer through the PGK1 glycolysis pathway. In vivo experiments explore the biological mechanisms behind PGK1-mediated breast cancer proliferation and invasion. Results High expression of PGK1 is significantly associated with poor prognosis in breast cancer patients, and resveratrol induces breast cancer cell apoptosis in a dose-dependent manner, inhibiting PK, PGK1, LDH enzyme activity and ATP content. Resveratrol inhibits PGK1 expression and its related c-Myc/PI3K/AKT signaling pathway. Western blot experiments show that resveratrol affects the biological functions of breast cancer by inhibiting PCNA, MMP2 and MMP9 proteins and activating BAX/Bcl-2 and Caspase3/7 proteins. In addition, in vivo experiments show that resveratrol significantly inhibits the growth of transplanted tumors in breast cancer mice and inhibits breast cancer tumor proliferation, invasion and metastasis by downregulating PGK1 expression. Conclusion Resveratrol demonstrates inhibitory effects on breast cancer cell proliferation, invasive and migration, as well as induction of apoptosis in vitro. It also inhibits the growth of mouse breast cancer transplantation tumors in vivo and exhibits oncostatic effects both in vitro and in vivo. Moreover, resveratrol reduces the expression of PGK1 in breast cancer BT-549 cells by regulating the transcription factors c-Myc. This regulation leads to the blockage of cellular glycolysis pathways, ultimately inhibiting the malignant biological behavior of breast cancer cells.

Resveratrol Reverses TGF-β1–Mediated Invasion and Metastasis of Breast Cancer Cells Via the SIRT3/AMPK/Autophagy Signal Axis

Resveratrol, an activator of SIRT1, induces protective autophagy in non-small-cell lung cancer via inhibiting Akt/mTOR and activating p38-MAPK

Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-κB pathway.

Pterostilbene Simultaneously Induces Apoptosis, Cell Cycle Arrest and Cyto-Protective Autophagy in Breast Cancer Cells.

Resveratrol Inhibits Breast Cancer Stem-Like Cells and Induces Autophagy Via Suppressing Wnt/β-catenin Signaling Pathway.

Mechanism of Resveratrol Affecting Biological Functions of Breast Cancer Through Glycolysis Pathway

[Corrigendum] Resveratrol Inhibits the Invasion and Metastasis of Colon Cancer Through Reversal of Epithelial‑mesenchymal Transition Via the AKT/GSK‑3β/Snail Signaling Pathway.

Resveratrol Enhances Inhibition Effects of Cisplatin on Cell Migration and Invasion and Tumor Growth in Breast Cancer MDA-MB-231 Cell Models In Vivo and In Vitro

Resveratrol suppresses the growth and metastatic potential of cervical cancer by inhibiting STAT3 Tyr705 phosphorylation

Resveratrol Inhibits Glioma Cell Growth Via Targeting Oncogenic Micrornas and Multiple Signaling Pathways

Resveratrol inhibits pancreatic cancer proliferation and metastasis by depleting senescent tumor-associated fibroblasts

STAT3 pathway as a molecular target for resveratrol in breast cancer treatment

Resveratrol represses estrogen-induced mammary carcinogenesis through NRF2-UGT1A8-estrogen metabolic axis activation

Resveratrol-mediated apoptosis in renal cell carcinoma via the p53/AMP‑activated protein kinase/mammalian target of rapamycin autophagy signaling pathway

Integrative investigation of the TF-miRNA coregulatory network involved in the inhibition of breast cancer cell proliferation by resveratrol

A novel anti‑cancer effect of resveratrol: reversal of epithelial‑mesenchymal transition in prostate cancer cells.

Metformin inhibits the tumor-promoting effect of low-dose resveratrol, and enhances the anti-tumor activity of high-dose resveratrol by increasing its reducibility in triple negative breast cancer

Resveratrol triggers autophagy‐related apoptosis to inhibit the progression of colorectal cancer via inhibition of FOXQ1

Resveratrol inhibits the growth of gastric cancer by inducing G1 phase arrest and senescence in a Sirt1-dependent manner

Resveratrol Inhibits Hypoxia-Driven ROS-induced Invasive and Migratory Ability of Pancreatic Cancer Cells Via Suppression of the Hedgehog Signaling Pathway.

Resveratrol Inhibits Invasion and Metastasis of Hepatocellular Carcinoma Cells